Clinical Trial

CAR-T Cells Therapy for Patients With Autoimmune Diseases

Name: CAR-T Cells Therapy for Patients With Autoimmune Diseases — clinical trial record (NCT07052565)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ECAR01

Recruiting

View on ClinicalTrials.gov →

Summary

This is an open label, single-site, dose-escalation study in up to 18 participants with refractory autoimmune diseases. This study aims to evaluate the safety and efficacy of the treatment with Anti-BCMA and CD19 CART

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-26.

Trial Details

NCT Number	NCT07052565
Lead Sponsor	Anhui Provincial Hospital
Conditions	Autoimmune Diseases
Enrollment	18 participants
Start Date	2025-07-20
Primary Completion	2028-11-01 (estimated)
Study Completion	2028-11-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-08